Global Neurosurgery Devices Market Size Study & Forecast, by Product (Neuromodulation, Neuroendoscopy) and Application (Chronic Pain, Depression, Parkinson's, Ischemia, Transnasal Neuroendoscopy) and Regional Forecasts 2022-2032

Description

Global Neurosurgery Devices Market is valued at approximately USD 13.5 billion in 2024 and is projected to expand at a robust CAGR of 13.00% over the forecast period 2025-2035. Neurosurgery devices encompass a wide array of instruments and equipment designed to aid in complex neurological procedures, ranging from minimally invasive surgeries to advanced neuromodulation therapies. These devices are critical in improving patient outcomes, enhancing surgical precision, and reducing recovery time. The market growth is largely fueled by rising prevalence of neurological disorders, increasing adoption of technologically advanced surgical solutions, and continuous investments in research and development across the globe.

The escalating incidence of chronic neurological conditions such as Parkinson's disease, chronic pain syndromes, depression, and ischemic disorders has significantly bolstered the demand for neurosurgical interventions. According to WHO data, neurological disorders affect more than one billion individuals worldwide, emphasizing the urgent need for effective treatment solutions. Additionally, advancements in neuromodulation devices, including spinal cord stimulation and deep brain stimulation, coupled with the growing adoption of neuroendoscopic procedures, have created new avenues for the market. However, stringent regulatory frameworks and high costs of advanced neurosurgery devices could pose challenges to market expansion during the forecast period.

From a regional perspective, North America dominated the global Neurosurgery Devices Market in 2025, driven by a well-established healthcare infrastructure, high healthcare expenditure, and extensive adoption of advanced neurosurgical technologies. The U.S., in particular, remains a significant contributor due to robust research initiatives and rising demand for minimally invasive neurosurgical solutions. Europe also accounts for a substantial market share, with Germany, France, and the UK leading in technological adoption and healthcare service expansion. The Asia Pacific region is projected to witness the fastest growth during 2025-2035, fueled by rapid urbanization, growing healthcare investments, increasing prevalence of neurological disorders, and rising awareness about advanced treatment options in countries such as China, India, and Japan. Latin America and the Middle East & Africa are gradually emerging as lucrative markets due to expanding healthcare infrastructure and government initiatives supporting medical device adoption.

Major market players included in this report are:

Medtronic Plc
Boston Scientific Corporation
Stryker Corporation
Abbott Laboratories
Johnson & Johnson
TheraCell Neuroscience
Globus Medical Inc.
Zimmer Biomet Holdings Inc.
Baxter International Inc.
NuVasive Inc.
Integra LifeSciences Corporation
Boston Scientific Neuromodulation Division
Cyberonics, Inc.
Fresenius Medical Care AG & Co. KGaA
Neuronetics Inc.

Global Neurosurgery Devices Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product:

Neuromodulation (Spinal Cord Stimulation, Deep Brain Stimulation)
Neuroendoscopy

By Application:

Chronic Pain
Depression
Parkinson's
Ischemia
Transnasal Neuroendoscopy

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035
Annualized revenues and regional level analysis for each market segment
Detailed analysis of geographical landscape with Country level analysis of major regions
Competitive landscape with information on major players in the market
Analysis of key business strategies and recommendations on future market approach
Analysis of competitive structure of the market
Demand side and supply side analysis of the market

Chapter 1. Global Neurosurgery Devices Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Neurosurgery Devices Market Forces Analysis

3.1. Market Forces Shaping The Global Neurosurgery Devices Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of neurological disorders (Parkinson's, chronic pain, depression, ischemia)
- 3.2.2. Adoption of advanced, minimally invasive neuromodulation & neuroendoscopy technologies
3.3. Restraints
- 3.3.1. Stringent regulatory approval frameworks for high-risk neurosurgical devices
- 3.3.2. High capital & procedure costs limiting affordability and access
3.4. Opportunities
- 3.4.1. Fast-growing demand across Asia Pacific with expanding healthcare investments
- 3.4.2. Broader clinical indications (DBS, SCS) and continuous R&D in navigation/robotics

Chapter 4. Global Neurosurgery Devices Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Neurosurgery Devices Market Size & Forecasts by Product 2025-2035

5.1. Market Overview
5.2. Global Neurosurgery Devices Market Performance - Potential Analysis (2025)
5.3. Neuromodulation
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Neuroendoscopy
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Neurosurgery Devices Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Neurosurgery Devices Market Performance - Potential Analysis (2025)
6.3. Chronic Pain
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Depression
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Parkinson's
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. Ischemia
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035
6.7. Transnasal Neuroendoscopy
- 6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.7.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Neurosurgery Devices Market Size & Forecasts by Region 2025-2035

7.1. Neurosurgery Devices Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Neurosurgery Devices Market
- 7.3.1. U.S. Neurosurgery Devices Market
  - 7.3.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Neurosurgery Devices Market
  - 7.3.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Application breakdown size & forecasts, 2025-2035
7.4. Europe Neurosurgery Devices Market
- 7.4.1. UK Neurosurgery Devices Market
  - 7.4.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Neurosurgery Devices Market
  - 7.4.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Neurosurgery Devices Market
  - 7.4.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Neurosurgery Devices Market
  - 7.4.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Neurosurgery Devices Market
  - 7.4.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Neurosurgery Devices Market
  - 7.4.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Application breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Neurosurgery Devices Market
- 7.5.1. China Neurosurgery Devices Market
  - 7.5.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Neurosurgery Devices Market
  - 7.5.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Neurosurgery Devices Market
  - 7.5.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Neurosurgery Devices Market
  - 7.5.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Neurosurgery Devices Market
  - 7.5.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Neurosurgery Devices Market
  - 7.5.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Application breakdown size & forecasts, 2025-2035
7.6. Latin America Neurosurgery Devices Market
- 7.6.1. Brazil Neurosurgery Devices Market
  - 7.6.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Neurosurgery Devices Market
  - 7.6.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Application breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Neurosurgery Devices Market
- 7.7.1. UAE Neurosurgery Devices Market
  - 7.7.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Neurosurgery Devices Market
  - 7.7.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Neurosurgery Devices Market
  - 7.7.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Medtronic Plc
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Boston Scientific Corporation
8.4. Stryker Corporation
8.5. Abbott Laboratories
8.6. Johnson & Johnson
8.7. TheraCell Neuroscience
8.8. Globus Medical Inc.
8.9. Zimmer Biomet Holdings Inc.
8.10. Baxter International Inc.
8.11. NuVasive Inc.
8.12. Integra LifeSciences Corporation
8.13. Boston Scientific Neuromodulation Division
8.14. Cyberonics, Inc.
8.15. Fresenius Medical Care AG & Co. KGaA
8.16. Neuronetics Inc.